Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Tag: SOP lifecycle management

Training Cross-Functional Teams on Shared SOPs

Posted on By

Training Cross-Functional Teams on Shared SOPs How to Effectively Train Cross-Functional Teams on Shared SOPs In the pharmaceutical industry, SOPs (Standard Operating Procedures) are not just departmental documents—they often span multiple functional areas like QA, QC, production, and regulatory affairs. Shared SOPs require harmonized understanding across teams to ensure synchronized operations, minimize deviations, and maintain…

Read More “Training Cross-Functional Teams on Shared SOPs” »

SOP Guidelines, SOP Training

Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness

Posted on By

Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness Overlooking SOP Revisions After Emergency Measures: A GMP Oversight Introduction to the Audit Finding 1. Emergency Measures Should Not Be Permanent Emergency actions in GMP operations are intended to be short-term responses — not lasting procedures unless properly documented and approved. 2. Risk of…

Read More “Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness” »

Emergency Changes, GMP Audit Findings

SOPs Reference Withdrawn Regulatory Guidance Documents — A Hidden Compliance Trap

Posted on By

SOPs Reference Withdrawn Regulatory Guidance Documents — A Hidden Compliance Trap When SOPs Cite Withdrawn Guidance: A Regulatory Red Flag in Pharma Introduction to the Audit Finding 1. Regulatory References Must Be Current SOPs that refer to withdrawn or outdated regulatory documents fail to ensure ongoing GMP compliance. 2. Obsolete Guidelines Invalidate SOP Content When…

Read More “SOPs Reference Withdrawn Regulatory Guidance Documents — A Hidden Compliance Trap” »

GMP Audit Findings, Regulatory Change

No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight

Posted on By

No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight GMP Risks of Skipping SOP Assessments After Regulatory Changes Introduction to the Audit Finding 1. Regulatory Changes Are Constant Health authorities worldwide frequently revise GMP standards, including FDA, EMA, WHO, and CDSCO updates. 2. SOPs Must Stay Current Every regulatory update should trigger a…

Read More “No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight” »

GMP Audit Findings, Regulatory Change

No Refresher Training on Critical SOPs: Risk to Compliance and Competency

Posted on By

No Refresher Training on Critical SOPs: Risk to Compliance and Competency Absence of Refresher Training on Critical SOPs: A Risk to GMP Compliance Introduction to the Audit Finding 1. Training Stagnation Employees undergo initial training but are not retrained on critical SOPs over time. 2. Compliance Erosion As procedures evolve, lack of refresher training results…

Read More “No Refresher Training on Critical SOPs: Risk to Compliance and Competency” »

GMP Audit Findings, SOP Training Failure

Posts pagination

Previous 1 2

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme